scholarly article | Q13442814 |
P356 | DOI | 10.1111/CGE.12601 |
P698 | PubMed publication ID | 25916247 |
P50 | author | Joris A Veltman | Q57687954 |
P2093 | author name string | M A Willemsen | |
T Kleefstra | |||
J Schieving | |||
L E L M Vissers | |||
L Krabbenborg | |||
S van der Burg | |||
P2860 | cites work | Next generation genetic counseling: introduction to the special issue | Q33894048 |
Informed consent for exome sequencing in diagnostics: exploring first experiences and views of professionals and patients | Q34507484 | ||
Lynch syndrome patients' views of and preferences for return of results following whole exome sequencing | Q35671138 | ||
What is ideal genetic counselling? A survey of current international guidelines | Q37057830 | ||
Stakeholders' opinions on the implementation of pediatric whole exome sequencing: implications for informed consent | Q37360685 | ||
Parental attitudes, values, and beliefs toward the return of results from exome sequencing in children | Q37595586 | ||
Informed consent for return of incidental findings in genomic research | Q37722733 | ||
SUDEP: what do parents want to know? | Q42625453 | ||
Feedback of individual genetic results to research participants: in favor of a qualified disclosure policy | Q44166679 | ||
The usefulness of whole-exome sequencing in routine clinical practice. | Q50657606 | ||
A de novo paradigm for mental retardation. | Q51828800 | ||
Parents' experiences of receiving their child's genetic diagnosis: a qualitative study to inform clinical genetics practice. | Q55520912 | ||
Diagnostic exome sequencing in persons with severe intellectual disability | Q55670486 | ||
Informed consent for whole genome sequencing: a qualitative analysis of participant expectations and perceptions of risks, benefits, and harms. | Q55711624 | ||
P433 | issue | 2 | |
P304 | page(s) | 244-250 | |
P577 | publication date | 2015-04-28 | |
P1433 | published in | Clinical Genetics | Q5133760 |
P1476 | title | Evaluating a counselling strategy for diagnostic WES in paediatric neurology: an exploration of parents' information and communication needs | |
P478 | volume | 89 |
Q38883296 | A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology |
Q90274646 | Challenges to informed consent for exome sequencing: A best-worst scaling experiment |
Q64040878 | Exome sequencing in clinical settings: preferences and experiences of parents of children with rare diseases (SEQUAPRE study) |
Q49720670 | Genetic Counseling in the Era of Genomics: What's all the Fuss about? |
Q41686977 | How do providers discuss the results of pediatric exome sequencing with families? |
Q91856722 | Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort |
Q56527776 | Incidental or secondary findings: an integrative and patient-inclusive approach to the current debate |
Q92141652 | Much ado about nothing: A qualitative study of the experiences of an average-risk population receiving results of exome sequencing |
Q47632310 | Not the End of the Odyssey: Parental Perceptions of Whole Exome Sequencing (WES) in Pediatric Undiagnosed Disorders |
Q57055341 | Opening the "black box" of informed consent appointments for genome sequencing: a multisite observational study |
Q97905170 | Parental experiences of ultrarapid genomic testing for their critically unwell infants and children |
Q53869120 | Patient perspectives on whole-genome sequencing for undiagnosed diseases. |
Q37421261 | Understanding the Psychosocial Effects of WES Test Results on Parents of Children with Rare Diseases |